Replies to post #11120 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

The quarter-to-quarter changes in NVS' Lovenox sales are now mostly noise, IMO. Dividing the 2013 total of $213M by 4 gives $53M as the quarterly average for the year, which is not much different from the $51M reported in 4Q13.